Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine
- Date
- Jul 18, 2026
- Company
- Unique Pharmaceutical Laboratories
- Brand
- Rising Pharma Holdings Inc.
- Product
- Cetirizine Hydrochloride Tablets USP 5 mg
- Reason
- Potential cross contamination with Ranitidine
- Hazard
- Other
- Source
- FDA
How to identify the product
- The product can be identified by reviewing the product name, manufacturer details and lot number displayed on the bottle.
- Product was distributed Nationwide to several wholesalers/retailers.
- (2 Tower Center Blvd., Suite 1401A, East Brunswick, NJ 08816) who has notified its distributors and direct customers by email and is arranging for the return of all recalled products.
Product photos are on the official FDA page.
Facts are taken from the official notice. If anything here differs from it, the official notice is correct.